To examine the anti-tumor effects of MKIs and a selective FGFR4 inhibitor in vivo, we conducted xenograft transplantation using Non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mice. The gene discussed is FGFR4; the disease is neoplasm.